We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PRPH market cap is 14.58M. The company's latest EPS is USD -0.7029 and P/E is -0.90.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.37M | 3.5M | 3.63M | 2.47M | 3.15M |
| Operating Income | -6.48M | -11.35M | -8.3M | -7.83M | -7.94M |
| Net Income | -5.14M | -8.75M | -6.27M | -6.15M | -6.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.88M | 14.51M | 79.04M | 122.65M | 44.38M |
| Operating Income | -3.24M | -3.99M | 9.8M | 23.6M | -21.61M |
| Net Income | -3.15M | -2.13M | 6.27M | 18.46M | -16.78M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 91.71M | 91.93M | 90.03M | 93.68M | 91.81M |
| Total Liabilities | 35.28M | 42.54M | 45.17M | 49.6M | 53.68M |
| Total Equity | 56.43M | 49.38M | 44.87M | 44.08M | 38.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.27M | 31.41M | 89.3M | 87.65M | 91.93M |
| Total Liabilities | 1.04M | 20.85M | 30.67M | 24.02M | 42.54M |
| Total Equity | 11.23M | 10.56M | 58.63M | 63.63M | 49.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.14M | -11.35M | -5.12M | -9.94M | -13.97M |
| Investing | -105k | -1.37M | 2.44M | 2.56M | 2.46M |
| Financing | 2.83M | 5.76M | 2.27M | 7.59M | 10.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -841k | -2.59M | -13.62M | 28.55M | -11.35M |
| Investing | 5.54M | -1.02M | -19.67M | -2.08M | -1.37M |
| Financing | -5.82M | 9.99M | 35.13M | -26.02M | 5.76M |
| Market Cap | 14.58M |
| Price to Earnings Ratio | -0.90 |
| Price to Sales Ratio | 0.34 |
| Price to Cash Ratio | 9.35 |
| Price to Book Ratio | 0.3 |
| Dividend Yield | - |
| Shares Outstanding | 23.87M |
| Average Volume (1 week) | 201.95k |
| Average Volume (1 Month) | 230.87k |
| 52 Week Change | -86.49% |
| 52 Week High | 7.48 |
| 52 Week Low | 0.6322 |
| Spread (Intraday) | 0.19 (24.05%) |
| Company Name | ProPhase Labs Inc |
| Address |
874 walker road dover, delaware 19904 |
| Website | https://www.prophaselabs.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
